Contract

Evaluation of Emergency Department blood borne virus testing

  • NHS England

F03: Contract award notice

Notice identifier: 2023/S 000-017280

Procurement identifier (OCID): ocds-h6vhtk-03d74e

Published 19 June 2023, 9:51am



Section one: Contracting authority

one.1) Name and addresses

NHS England

1st Floor, Quarry House, Quarry Hill

Leeds

LS2 7UE

Contact

Commercial Contract Manager

Email

england.commercialqueries@nhs.net

Country

United Kingdom

Region code

UKE - Yorkshire and the Humber

Internet address(es)

Main address

https://www.england.nhs.uk//

Buyer's address

https://www.england.nhs.uk//

one.4) Type of the contracting authority

National or federal Agency/Office

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Evaluation of Emergency Department blood borne virus testing

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

Evaluation of Emergency Department blood borne virus
testing

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £400,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

National

two.2.4) Description of the procurement

The evaluation of the Emergency Department (ED) Blood borne virus (BBV) opt out testing project. As part of the Government’s HIV Action Plan published in Dec 2021 the Government committed to provide £20m of funding to NHS
England across three years to support the introduction of opt-out testing for HIV in 34 EDs in locations with the highest prevalence of HIV diagnosed.

This will support efforts to achieve the Government target of zero HIV transmissions in England by 2030. We have partnered with the NHSE Eliminating Hepatitis C programme team to include Hepatitis B and Hepatitis C testing in a BBV testing approach.

UKHSA and academic partners will undertake monitoring and evaluation to optimise the opt-out testing programme in terms of individual and public health benefits as well as value for money, a three-pronged evaluation approach is proposed: combining public health monitoring and evaluation, economic evaluation (collecting mainly quantitative data) as well as implementation optimisation / behavioural science research (collecting mainly qualitative data) to guide optimisation and standardisation and any
future roll-out of ED testing in lower prevalence sites.
Available demographic data on age, sex, ethnicity and deprivation (based on IMD of home address) will be used to investigate differences in testing and diagnosis to explore inequalities related to testing and accessing of treatment.
This analysis will support sites in targeting interventions (e.g. assertive outreach and increased use of peer support) at populations who are less likely to engage and maintain contact with treatment services, and thus align our work with CORE5PLUS aims.

This project has seen considerable early successes. External evaluation will ensure that we maximise the learning opportunities to inform clinical practice and BBV policy, and to demonstrate that this approach is both effective in reaching disadvantaged groups and cost effective.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

Criteria for STA: One economic operator due to exclusive rights, including intellectual property rights

Justification of STA Criteria and Reason: UKHSA is responsible for surveillance of HIV and viral hepatitis in England. This evaluation requires the matching of site level reported data with the national surveillance data, and UKHSA is the only organisation able to do this.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

23 May 2023

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

UK HEALTH SECURITY AGENCY (UKHSA)

3rd Floor, 2 Rivergate

Bristol

BS1 6EH

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £400,000

Lowest offer: £400,000 / Highest offer: £400,000 taken into consideration


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

Country

United Kingdom

Internet address

https://www.judiciary.uk/courts-and-tribunals/high-court/

six.4.2) Body responsible for mediation procedures

The High Court

The Strand

London

WC2A 2LL

Country

United Kingdom

Internet address

https://www.judiciary.uk/courts-and-tribunals/high-court/